The improvement in depression correlated with normalization of pro-inflammatory biomarkers, including pro-inflammatory adipokines (leptin) or cytokine (IL-6), suggests a role for inflammatory pathways and intriguing links between PPARγ activation, depression, and inflammation [45,51]. This evidence concerns the gene PPARG and depressive symptom measurement.